When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Rotor syndrome

Evidence last reviewed: 14 Mar 2026
Topic last updated: 10 Dec 2024

Summary

Definition

History and exam

Key diagnostic factors

  • jaundice
  • dark-colored urine
Full details

Other diagnostic factors

  • fatigue
  • abdominal pain
Full details

Risk factors

  • glucose-6-phosphate dehydrogenase deficiency
  • beta-thalassemia
Full details

Diagnostic tests

1st tests to order

  • serum total bilirubin
  • serum conjugated bilirubin
  • urinary bilirubin
  • serum aminotransferases, alkaline phosphatase, and gamma-GT
  • hemoglobin
  • absolute reticulocyte count
  • blood smear
  • plasma haptoglobin
Full details

Tests to consider

  • serum bile acids (total)
  • urinary coproporphyrins
  • liver biopsy
  • ultrasound of the liver and biliary tree
  • oral cholecystogram
  • cholescintigraphy with 99mTc-HIDA
  • molecular genetic testing
  • sulphobromophthalein (BSP) plasma retention test
Full details

Treatment algorithm

ONGOING

all patients

Contributors

Authors

Tracy A.F. Coelho, MBBS, DCH, MRCPCH
Tracy A.F. Coelho

Consultant Paediatric Gastroenterologist

University Hospital Southampton

Southampton

UK

Disclosures

TAFC declares that he has no competing interests.

Anil Dhawan, MBBS, MD, FRCPCH
Anil Dhawan

Professor of Paediatric Hepatology

King's College Hospital

London

UK

Disclosures

AD declares that he has no competing interests.

Revisores

John T. Jenkins, MB, CHB, FRCP

Consultant Surgeon

St. Mark's Hospital

London

UK

Declarações

JTJ declares that he has no competing interests.

William A. Petri, Jr., MD, PhD, FACP

Chief and Professor of Medicine

Division of Infectious Diseases and International Health

University of Virginia Health System

Charlottesville

VA

Declarações

WAP declares that he has no competing interests.

Nancy Reau, MD

Assistant Professor of Medicine

University of Chicago

Center for Liver Disease

Chicago

IL

Declarações

NR has received reimbursement for speaking for Gilead, maker of Viread and Hepsera, and BMS, maker of Baraclude.

James Neuberger, BM, BCh

Consultant Physician

Liver Unit

Queen Elizabeth Hospital

Birmingham

UK

Declarações

JN declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Rotor AB, Manahan L, Florentin A. Familial non-hemolytic jaundice with direct Van Den Bergh reaction. Acta Med Phil. 1948;5:37-49.

Vest MF, Kaufmann HJ, Fritz E. Chronic non-haemolytic jaundice with conjugated bilirubin in the serum and normal histology: a case study. Arch Dis Child. 1960;36:600-4.Texto completo  Resumo

Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017 Jan;112(1):18-35.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad